Barely Significant
← all excerpts

Impact of denosumab on bone mass in cancer patients.

Clin Pharmacol · 2013 · PMC3707483 · PMID 23861604

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significanceP = 0.10so close (0.05 < p ≤ 0.1)
Fractures at any site also occurred in fewer denosumab-treated patients compared with the placebo group (38 patients [5.2%] versus 53 patients [7.2%]); however, this did not reach statistical significance ( P = 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.